Michel Vounatsos

2019

In 2019, Michel Vounatsos earned a total compensation of $18.2M as Chief Executive Officer at Biogen, a 12% increase compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$85,667
Non-Equity Incentive Plan$3,884,000
Salary$1,388,461
Stock Awards$12,352,030
Other$449,700
Total$18,159,858

Vounatsos received $12.4M in stock awards, accounting for 68% of the total pay in 2019.

Vounatsos also received $85.7K of change in pension value and nonqualified deferred compensation earnings, $3.9M in non-equity incentive plan, $1.4M in salary and $449.7K in other compensation.

Rankings

In 2019, Michel Vounatsos' compensation ranked 215th out of 13,971 executives tracked by ExecPay. In other words, Vounatsos earned more than 98.5% of executives.

ClassificationRankingPercentile
All
215
out of 13,971
99th
Division
Manufacturing
78
out of 5,695
99th
Major group
Chemicals And Allied Products
21
out of 2,194
99th
Industry group
Drugs
17
out of 1,880
99th
Industry
Biological Products, Except Diagnostic Substances
2
out of 389
100th

Pay ratio

Michel Vounatsos' Pay$18,159,858
Median Employee's Pay$159,721
Pay Ratio

114

to 1

In 2019, the annual total compensation of Michel Vounatsos was $18,159,858.

The annual total compensation of the median employee at Biogen was $159,721.

The ratio of Michel Vounatsos' pay to the pay of median employee was therefore 114 to one.

Source: SEC filing on April 20, 2020.

Vounatsos' colleagues

We found five more compensation records of executives who worked with Michel Vounatsos at Biogen in 2019.

2019

Jeffrey Capello

Biogen

Chief Financial Officer

2019

Susan Alexander

Biogen

Chief Legal Officer

2019

Alfred Sandrock

Biogen

Executive Vice President, Research & Development

2019

Michael Ehlers

Biogen

Former Executive Vice President Research Development

2019

Chirfi Guindo

Biogen

Executive Vice President, Global Product Strategy and Commercialization

News

You may also like